"Grande International Hospital was created with the vision to fill an existing void in the Nepali healthcare industry. It is dedicated to the seamless delivery of quality, patient-centric healthcare—which means supplying everything a patient may need, from acute critical care to rehabilitation to transitional care to home healthcare services—at an affordable cost. Our goal is to establish in this country a culture of continuous improvement in healthcare—not only by providing excellent healthcare services but also by conducting community health education seminars, outreach programs, and wellness programs in several parts of Nepal."

During the past decade, Grande International Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grande International Hospital" #1 collaborator was "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Berry Consultants" with 1 trials as a collaborator, "Global Coalition for Adaptive Research" with 1 trials as a collaborator, "Intensive Care National Audit & Research Centre" with 1 trials as a collaborator and "Medical Research Institute of New Zealand" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Grande International Hospital" are "Atrial Fibrillation" (1 trials), "Community-acquired Pneumonia, Influenza, COVID-19" (1 trials) and "Intracranial Hemorrhages" (1 trials). Many other conditions were trialed in "Grande International Hospital" in a lesser frequency.

Most popular intervention types in "Grande International Hospital" are "Drug" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ARB + DMX-200" (1 trials), "Amoxicillin-clavulanate" (1 trials), "Anakinra" (1 trials), "Angiotensin Receptor Blockers" (1 trials) and "Angiotensin converting enzyme inhibitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Grande International Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Grande International Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Grande International Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Grande International Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".